Work

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

Year: 2020

Type: article

Source: Leukemia

DOI: 10.1038/s41375-020-0766-4

Institutions: Mayo Clinic, Mayo Clinic in Florida, Celgene (United States), University of Iowa

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G2660289629, G3572864229, G3723508571, Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W3010064674

FWCI: 3.64

Cites: 64

Cited by: 48

Related to: 10